These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6937966)

  • 1. Netilmicin 200 mg twice a day for adult patients with life-threatening infections. A preliminary report.
    Perera MR; Amirak ID; Noone P
    Scand J Infect Dis Suppl; 1980; Suppl 23():186-8. PubMed ID: 6937966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose netilmicin therapy of severe or chronic infections.
    Hellum KB; Madsen ST; Digranes A; Stokstad S; Solberg CO
    Scand J Infect Dis Suppl; 1980; Suppl 23():189-94. PubMed ID: 6937967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Netilmicin in urinary tract infections.
    Svare J; Johnsen NJ; Vesterhauge S; Lund F; Thomsen J; Vejlsgaard R
    Scand J Infect Dis Suppl; 1980; Suppl 23():132-4. PubMed ID: 6937957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of netilmicin-cefoxitin and gentamicin-cefoxitin in surgical patients with serious systemic infection.
    Bubrick MP; Howard RJ; Pancorbo S; Lorber RR; Chin TW; Yost R
    Clin Ther; 1983; 5(5):515-24. PubMed ID: 6352035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netilmicin: efficacy and tolerance in the treatment of systemic infections in neonates.
    Peitersen B; Hørlyk H; Nielsen M; Prag J; Korner B; Heilesen AM; Friis-Møller A
    Scand J Infect Dis Suppl; 1980; Suppl 23():151-4. PubMed ID: 6937961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections.
    Buckwold FJ; Ronald AR; Lank B; Thompson L; Fox L; Harding GK
    Can Med Assoc J; 1979 Jan; 120(2):161-7. PubMed ID: 761144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized comparison of the efficacy and safety of netilmicin-clindamycin and tobramycin-clindamycin in the treatment of serious systemic infections.
    Kahalley S; Chandler J; Hawkins J; Norris G; Waugespack R; Snow RM
    Clin Ther; 1985; 7(4):497-506. PubMed ID: 4016829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of netilmicin, 150 mg BID, in systemic infections.
    Tambic T; Kropec I; Kosuta D
    Clin Ther; 1981; 4(1):43-7. PubMed ID: 7023679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Netilmicin therapy of patients with septicaemia and other severe infections.
    Brandenhoff P; Stafanger G; Gammelgaard PA; Rasmussen F; Jensen SH; Bretlau P; Thomsen VF
    Scand J Infect Dis Suppl; 1980; Suppl 23():181-5. PubMed ID: 6937965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netilmicin in moderate to severe infections in newborns and infants: a study of efficacy, tolerance and pharmacokinetics.
    Henriksson P; Svenningsen NW; Juhlin I; Haeger K
    Scand J Infect Dis Suppl; 1980; Suppl 23():155-9. PubMed ID: 7010546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Netilmicin therapy of patients with leukaemia or malignant lymphoma.
    Geisler C; Hansen MM; Mortensen N; Traun-Pedersen P
    Scand J Infect Dis Suppl; 1980; Suppl 23():176-80. PubMed ID: 6937964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity, high frequency ototoxicity, efficacy and serum kinetics of once versus thrice daily dosing of netilmicin in patients with serious infections.
    Blaser J; Simmen HP; Thurnheer U; König C; Lüthy R
    J Antimicrob Chemother; 1995 Nov; 36(5):803-14. PubMed ID: 8626261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter comparative evaluation of netilmicin and gentamicin in adult patients. Efficacy and safety.
    Herting RL; Lorber RR; Miller M; Danzig MR
    Arzneimittelforschung; 1981; 31(2):366-70. PubMed ID: 7194655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Netilmicin in the treatment of neonates with moderate and severe infections.
    Michalsen H; Halvorsen K; Bergan T
    Scand J Infect Dis Suppl; 1980; Suppl 23():146-50. PubMed ID: 6937960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Netilmicin: chemical development and overview of clinical research.
    Herting RL; Lane AZ; Lorber RR; Wright JJ
    Scand J Infect Dis Suppl; 1980; Suppl 23():20-9. PubMed ID: 7010547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Netilmicin treatment of complicated urinary tract infections.
    Madsen PO; Baumueller A; Frimodt-Møller N; Hoyme U; Lau C; Maigaard S; Nielsen OS; Welling PG
    Scand J Infect Dis Suppl; 1980; Suppl 23():128-31. PubMed ID: 6937956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Netilmicin: clinical evaluation of efficacy and toxicity of a new aminoglycoside.
    Nordström L; Christensson P; Haeger K; Juhlin I; Tjernström O; Wallmark E
    J Int Med Res; 1979; 7(2):117-26. PubMed ID: 478159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Netilmicin use in pediatric patients.
    Chindasilpa V; Schauf V; Hamilton LR; Riff LJ
    Dev Pharmacol Ther; 1980; 1(4):238-53. PubMed ID: 7438970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W; Schwarz A
    Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin therapy administered by intermittent intravenous injections.
    Korner B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:15-2. PubMed ID: 4521603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.